Seroprevalence of Specific SARS-CoV-2 Antibodies during Omicron BA.5 Wave, Portugal, April–June 2022

After the rapid spread of SARS-CoV-2 BA.5 Omicron lineage in Portugal, we developed a seroepidemiologic survey based on a sample of 3,825 residents. Results indicated that from April 27 through June 8, 2022, the estimated seroprevalence of SARS-CoV-2 nucleocapsid or spike IgG was 95.8%, which indica...

Descripción completa

Detalles Bibliográficos
Autores principales: Kislaya, Irina, Melo, Aryse, Barreto, Marta, Henriques, Camila, Aniceto, Carlos, Manita, Carla, Ramalhete, Sara, Santos, João Almeida, Soeiro, Sofia, Rodrigues, Ana Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973687/
https://www.ncbi.nlm.nih.gov/pubmed/36732078
http://dx.doi.org/10.3201/eid2903.221546
Descripción
Sumario:After the rapid spread of SARS-CoV-2 BA.5 Omicron lineage in Portugal, we developed a seroepidemiologic survey based on a sample of 3,825 residents. Results indicated that from April 27 through June 8, 2022, the estimated seroprevalence of SARS-CoV-2 nucleocapsid or spike IgG was 95.8%, which indicates a high level of protection.

Ejemplares similares